Clinical Trials Logo

Clinical Trial Summary

The primary aim of this study is to investigate the efficacy of 8 weeks of Low-load blood flow restricted exercise (BFRE) compared to receiving standard care only (no preoperative training) before total knee replacement (TKR) on postoperative 30-seconds chair stand test (30s-CST). We hypothesize that 8 weeks of preoperative BFRE will increase chair stand performance 3 months postoperatively. Secondary aims are to investigate the efficacy of 8 weeks of preoperative BFRE compared to receiving standard care only on changes in muscle strength 3 months after TKR and investigate associations to functional capacity and quality of life. Furthermore, it will be investigated if 8 weeks of BFRE induces muscle hypertrophy and increases satellite cell and myonuclei content of the vastus lateralis muscle.


Clinical Trial Description

BFRE is resistance training with low loads (30% 1repetition maximum (RM) performed with concurrent partial blood flow restriction by means of pneumatic cuff compression around the working limb. Group 1 (BFRE): BFRE group: Will perform 3/weekly supervised BFRE sessions for 8 weeks from a physiotherapist educated in administering BFRE. Each session will consist of a 10-min warm up followed by two different unilateral lower-limb resistance training exercises: leg press and knee extension. Each exercise will be performed with the affected lower limb only and consist of 4 rounds interspaced by 30 seconds of rest. 1st round: 30 repetitions (reps); 2nd round: 15 reps; 3rd round: 15 reps; 4th round: until exhaustion. Between each exercise the patients will rest for 5 minutes without blood flow restriction. Patients will rest in a standardized resting position between each set to maintain the desired resting cuff-pressure. The occlusion pressure will be set at 60% of total limb occlusion pressure and starting load intensity will be 30% 1repetition maximum (1RM) in both exercises. If patients can perform more than 15 repetitions in the 4th exercise set, the exercise load will be increased with the minimum extra load possible. Group 2 (control Group): CON group: Will follow standard procedures before a TKA and be encouraged to live their lives as usual up until TKA. The study is a multicenter (2 sites), randomized (allocation 1:1), assessor blinded, controlled trial Outcomes will be measured at baseline (9-10 weeks before surgery), in the week of surgery and 3- and 12 months postoperatively. Muscle biopsies will be taken from all patients undergoing surgery at Horsens Regional Hospital. Muscle biopsies will be taken at baseline, during surgery and 3 months postoperatively. The 12 months follow-up assessment will be analyzed and presented in papers during a subsequent Post Doc-period. All patients will be scheduled to receive TKR and receive a standard multimodal surgical program with standardized perioperative care. Specifically, all patients will be invited to a preoperative information meeting 2-3 weeks prior to surgery where nurses, surgeons, and physiotherapists will be providing detailed information about pain management, nutrition, the surgical procedure (i.e. basic knowledge about a prosthesis, risks related to smoking, restrictions related to living with a TKR, long-term results, and living with a TKR), physical activity, postoperative home-based rehabilitation, load-management, etc. On the day of surgery patients will be hospitalized at one of the two orthopedic departments and TKR procedures will be performed by an orthopedic surgeon. The day after surgery patients will be trained once or twice per day by a physiotherapist towards fulfilling the following discharge criterions: independency in in-and-out of bed and sit-to-stand activities, independency in walking and stair-negotiation with crutches, ADL activities, and home-based exercises during the hospitalization period. Patients will generally be discharged within ~1-2 days after fulfilling all the above discharge criteria. After discharge, all patients will receive a standard home-based rehabilitation program aimed at increasing knee mobility and lower extremity muscle strength. However, if considered necessary by the physiotherapist in charge of the patient, patients can receive additional supervised knee-specific exercise therapy at private physiotherapy clinics, municipal rehabilitation centers, or specialized hospital-based rehabilitation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04081493
Study type Interventional
Source University of Aarhus
Contact
Status Completed
Phase N/A
Start date September 17, 2019
Completion date April 1, 2024

See also
  Status Clinical Trial Phase
Terminated NCT04040985 - Legion Primary Safety and Efficacy N/A
Recruiting NCT05279092 - Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study Phase 2
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Not yet recruiting NCT04594447 - Physica System KR vs Physica System CR (K-20) N/A
Completed NCT02413996 - Effects of Virtual Reality Rehabilitation in Patients With Total Knee Arthroplasty N/A
Completed NCT01500252 - Patellar Resurfacing Versus Patellar Retention in Total Knee Arthroplasty - A Randomized Clinical Trial Phase 4
Active, not recruiting NCT03339557 - Comparison of Three Knee Replacements N/A
Enrolling by invitation NCT04513145 - Adductor Canal Block Phase 2/Phase 3
Completed NCT06045078 - Aromatherapy in Total Knee Replacement N/A
Completed NCT02468934 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty (TKA) Using the SPRINT System N/A
Completed NCT02914210 - Virtual vs. Traditional Physical Therapy Following Total Knee Replacement N/A
Withdrawn NCT01523418 - Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement) N/A
Completed NCT00795223 - Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA Phase 4
Completed NCT01307202 - Morphine Consumption in Joint Replacement Patients, With or Without Gabapentin Treatment N/A
Completed NCT01522781 - 10 Year Outcome of Total Knee Replacement (TKR) Using Sigma Prosthesis N/A
Completed NCT01515449 - Predictors of Poor Outcomes in 1038 Sigma Knees N/A
Completed NCT04166539 - Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty
Completed NCT03454256 - Virtual Reality Rehabilitation in Patients With Total Knee Replacement N/A
Enrolling by invitation NCT06118073 - Effect of Mindfulness on Pain After Total Knee Arthroplasty N/A
Completed NCT05597046 - Qualitative Interviews With Healthcare Professionals